Chon P. Ong
Lika, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
CRISPR/Cas13-Mediated Inhibition of EBNA1 for Suppression of Epstein-Barr Virus Transcripts and DNA Load in Nasopharyngeal Carcinoma Cells.
Journal: Viruses
Published: June 09, 2025
Activation of PD-1/PD-L1 immune checkpoint by Zika virus.
Journal: PLoS pathogens
Published: March 26, 2025
A live attenuated SARS-CoV-2 vaccine constructed by dual inactivation of NSP16 and ORF3a.
Journal: EBioMedicine
Published: June 19, 2024
Nsp1 facilitates SARS-CoV-2 replication through calcineurin-NFAT signaling.
Journal: mBio
Published: February 27, 2024
Identification of novel small-molecule inhibitors of SARS-CoV-2 by chemical genetics.
Journal: Acta pharmaceutica Sinica. B
Published: December 05, 2023
Development of Pan-Anti-SARS-CoV-2 Agents through Allosteric Inhibition of nsp14/nsp10 Complex.
Journal: ACS infectious diseases
Published: October 28, 2023
Comparative analysis of SARS-CoV-2 Omicron BA.2.12.1 and BA.5.2 variants.
Journal: Journal of medical virology
Published: October 17, 2022
The spike receptor-binding motif G496S substitution determines the replication fitness of SARS-CoV-2 Omicron sublineage.
Journal: Emerging microbes & infections
Published: August 09, 2022
Production of single-cycle infectious SARS-CoV-2 through a trans-complemented replicon.
Journal: Journal of medical virology
Published: July 04, 2022
Pathogenicity, transmissibility, and fitness of SARS-CoV-2 Omicron in Syrian hamsters.
Journal: Science (New York, N.Y.)
Published: June 23, 2022
Cross-variant protection against SARS-CoV-2 infection in hamsters immunized with monovalent and bivalent inactivated vaccines.
Journal: International journal of biological sciences
Published: February 17, 2022
Last Updated: 09/26/2026